Room for improvement in clinical trials for rare diseases
NATURE REVIEWS RHEUMATOLOGY(2020)
摘要
Trials studying rare diseases, including immune-mediated inflammatory diseases such as Castleman disease, hyper IgD syndrome and undifferentiated vasculitis, frequently end in noncompletion and nonpublication. A new cross-sectional analysis identifies underlying reasons, but also calls for action to establish international networks that might facilitate recruitment of patients into trials and to ensure timely publication of research findings to advance the field.
更多查看译文
关键词
Clinical trials,Rheumatology,Medicine/Public Health,general
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要